134 related articles for article (PubMed ID: 19106616)
1. The p53 mRNA-Mdm2 interaction.
Naski N; Gajjar M; Bourougaa K; Malbert-Colas L; Fåhraeus R; Candeias MM
Cell Cycle; 2009 Jan; 8(1):31-4. PubMed ID: 19106616
[TBL] [Abstract][Full Text] [Related]
2. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
3. Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
Clegg HV; Itahana Y; Itahana K; Ramalingam S; Zhang Y
PLoS One; 2012; 7(5):e38212. PubMed ID: 22666487
[TBL] [Abstract][Full Text] [Related]
4. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.
Gajjar M; Candeias MM; Malbert-Colas L; Mazars A; Fujita J; Olivares-Illana V; Fåhraeus R
Cancer Cell; 2012 Jan; 21(1):25-35. PubMed ID: 22264786
[TBL] [Abstract][Full Text] [Related]
5. MDM2's dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities.
Gnanasundram SV; Malbert-Colas L; Chen S; Fusée L; Daskalogianni C; Muller P; Salomao N; Fåhraeus R
Nucleic Acids Res; 2020 Jul; 48(12):6775-6787. PubMed ID: 32453417
[TBL] [Abstract][Full Text] [Related]
6. p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2.
Karakostis K; Ponnuswamy A; Fusée LT; Bailly X; Laguerre L; Worall E; Vojtesek B; Nylander K; Fåhraeus R
Mol Biol Evol; 2016 May; 33(5):1280-92. PubMed ID: 26823446
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
8. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
[TBL] [Abstract][Full Text] [Related]
9. RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity.
Kawai H; Lopez-Pajares V; Kim MM; Wiederschain D; Yuan ZM
Cancer Res; 2007 Jul; 67(13):6026-30. PubMed ID: 17616658
[TBL] [Abstract][Full Text] [Related]
10. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Catalytic Active but Non-Aggregating MDM2 RING Domain Variant.
Magnussen HM; Huang DT
J Mol Biol; 2021 Mar; 433(5):166807. PubMed ID: 33450248
[TBL] [Abstract][Full Text] [Related]
12. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
13. Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.
Wei J; Yang Y; Lu M; Xu L; Liu F; Yuan Z; Bao Q; Jiang Z; Xu X; Guo X; Zhang X; You Q; Sun H
Anticancer Agents Med Chem; 2015; 16(2):174-89. PubMed ID: 26343143
[TBL] [Abstract][Full Text] [Related]
14. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
Wang X
Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
[TBL] [Abstract][Full Text] [Related]
15. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
Ofir-Rosenfeld Y; Boggs K; Michael D; Kastan MB; Oren M
Mol Cell; 2008 Oct; 32(2):180-9. PubMed ID: 18951086
[TBL] [Abstract][Full Text] [Related]
16. A genetic approach to mapping the p53 binding site in the MDM2 protein.
Freedman DA; Epstein CB; Roth JC; Levine AJ
Mol Med; 1997 Apr; 3(4):248-59. PubMed ID: 9131587
[TBL] [Abstract][Full Text] [Related]
17. Unlocking the Mdm2-p53 loop: ubiquitin is the key.
Clegg HV; Itahana K; Zhang Y
Cell Cycle; 2008 Feb; 7(3):287-92. PubMed ID: 18235222
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
19. p53 binds the mdmx mRNA and controls its translation.
Tournillon AS; López I; Malbert-Colas L; Findakly S; Naski N; Olivares-Illana V; Karakostis K; Vojtesek B; Nylander K; Fåhraeus R
Oncogene; 2017 Feb; 36(5):723-730. PubMed ID: 27375027
[TBL] [Abstract][Full Text] [Related]
20. MDM2 chaperones the p53 tumor suppressor.
Wawrzynow B; Zylicz A; Wallace M; Hupp T; Zylicz M
J Biol Chem; 2007 Nov; 282(45):32603-12. PubMed ID: 17848574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]